Skip to main content
TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
134.77
+5.16 (3.98%)
At close: Mar 9, 2026, 4:00 PM EDT
134.00
-0.77 (-0.57%)
After-hours: Mar 9, 2026, 5:08 PM EDT

TransMedics Group Revenue

In the year 2025, TransMedics Group had annual revenue of $605.49M with 37.13% growth. TransMedics Group had revenue of $160.76M in the quarter ending December 31, 2025, with 32.18% growth.

Revenue (ttm)
$605.49M
Revenue Growth
+37.13%
P/S Ratio
7.43
Revenue / Employee
$674,269
Employees
898
Market Cap
4.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025605.49M163.95M37.13%
Dec 31, 2024441.54M199.92M82.74%
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 2020 Pro Pro Pro
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bruker 3.44B
Bio-Rad Laboratories 2.58B
Bio-Rad Laboratories 2.58B
Integer Holdings 1.85B
Masimo 1.53B
LivaNova 1.39B
Haemonetics 1.32B
Alphatec Holdings 764.16M
Revenue Rankings

TMDX News

More News